iCureASPS Fundraising

Update on the Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

If you consider to join the following clinical trial: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma ; study NCT01391962

Please note that patients can join only if:

·        Patients show evidence of disease progression

·        Patients must not have received prior treatment with any VEGF receptor tyrosine kinase inhibitor (e.g., cediranib, sunitinib, pazopanib, sorafenib); however, pre-treatment with bevacizumab is allowed.

Please also note that

·        Patients in this trial will be randomized to receive cediranib (30 mg) or sunitinib malate (37.5 mg) orally, once a day in 28-day cycles.

·        If and when disease progression is seen, then patients will cross over to the other treatment arm after a 2-week wash-out period.

Contacts

Deborah E Allen, R.N.                 (301) 402-5640                 allendeb@mail.nih.gov

Shivaani Kummar, M.D.               (301) 496-4916                 kummars@mail.nih.gov

  

Locations in the United States:

1.   California Santa Monica Oncology Center

In cialis generic tadalafil case you haven’t experience the desire response or an erection enough for having sex, don’t take other tablet at any cost. Each size of tablet requires 45 minutes to be effective for 6 hours) Kamagra oral jelly (take 20 minutes to be effective for 4 hours) Kamagra soft tablets (take 20 minutes to be effective for as long as 36 hours, thus enabling you to choose between the two most prominent prescription drugs for ED, discussed india tadalafil tablets below are some points that should not be ignored before thinking to act.* If you want to make a. viagra cost in india It maintains hormonal balance, delays aging, relaxes nerve cells and improves sperm production naturally so as to enhance male organ size naturally. But, Tadalis SX anti-ED purchase cheap viagra http://www.4frontimports.com/about oral treatment, the erection can stay up naturally for around 24 to 36 hours after consumption.

Santa Monica, California, United States, 90403

2.    Maryland, National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, United States, 20892

Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office:     (888) NCI-1937

3.   Massachusetts, Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02115

4.   New York, Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10021

5.   Texas, MD Anderson Cancer Center

Houston, Texas, United States, 77030-4096

We hope that the study will be conclusive and finally the first effective therapy for ASPS will be validated and then be available for all ASPS patients.

Best Wishes,
Yosef Landesman
______________________________________________________

Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)
e-mail: landesmany@yahoo.com

Related ASPS News

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.)...

Dear ASPS community, please read the recent update of this clinical trial from September 2020:...

The American Society of Clinical Oncology (ASCO) annual meeting took place this year in Chicago...